Korro Bio (KRRO) Exchange Rate Effect (2024 - 2026)
Korro Bio's (KRRO) quarterly Exchange Rate Effect came in at $22000.0 in Q2 2026, up 344.44% on a YoY basis from $4950.0 in Q2 2025, and up 188.0% quarter-over-quarter from -$25000.0 in Q1 2026.
Analysis
Korro Bio (KRRO) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Korro Bio (KRRO) has reported Exchange Rate Effect for 3 consecutive years, with $22000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Exchange Rate Effect rose 344.44% year-over-year to $22000.0; the trailing twelve-month figure through Jun 2026 stood at $70000.0 (up 638.46% YoY), and the FY2025 full-year result was $64000.0, up 1700.0% from the prior year.
- Exchange Rate Effect rose to $22000.0 in Q2 2026 per KRRO's latest filing, from -$25000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $75000.0 in Q4 2025 and bottomed at -$25000.0 in Q1 2026.
- Historically, Exchange Rate Effect has averaged $9500.0 across 3 years, with a median of -$3000.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect soared 1975.0% in 2025, then soared 344.44% in 2026.
- Over 3 years, Exchange Rate Effect stood at -$4000.0 in 2024, then jumped by 1975.0% to $75000.0 in 2025, then sank by 70.67% to $22000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $22000.0, -$25000.0, and $75000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | Korro Bio | 231.15 Mn | 116.12 Mn | - | 22,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | -25,000.00 |
| Dec 31, 2025 | 75,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -9,000.00 |
| Dec 31, 2024 | -4,000.00 |